China Genotyping Market Size & Outlook, 2023-2030
China genotyping market, 2018-2030 (US$M)
Related Markets
China genotyping market highlights
- The China genotyping market generated a revenue of USD 914.7 million in 2023 and is expected to reach USD 2,712.2 million by 2030.
- The China market is expected to grow at a CAGR of 16.8% from 2024 to 2030.
- In terms of segment, reagents & kits was the largest revenue generating product in 2023.
- Reagents & kits is the most lucrative product segment registering the fastest growth during the forecast period.
Genotyping market data book summary
| Market revenue in 2023 | USD 914.7 million |
| Market revenue in 2030 | USD 2,712.2 million |
| Growth rate | 16.8% (CAGR from 2023 to 2030) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & kits |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & kits, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Roche, Fluidigm Corporation, Danaher Corp, Agilent Technologies, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, China accounted for 5.1% of the global genotyping market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan genotyping market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,181.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genotyping Market Scope
Genotyping Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China genotyping market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genotyping market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 61.24% in 2023. Horizon Databook has segmented the China genotyping market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2018 to 2030.
The market in China is expected to witness rapid growth during the forecast period due to growing application of genotyping in personalized medicine. The country’s healthcare policies are focused on developing novel technologies and improving R&D activities to enhance healthcare facilities.
With increasing population, healthcare expenditure in the country is also growing. Increased need for early diagnosis of diseases to reduce treatment costs & mortality rate is expected to boost demand for genotyping products. This is expected to lead to increased national income and better patient outcomes.
Global players are undertaking strategic initiatives to strengthen their foothold in China market. For instance, Illumina collaborated with Sequoia Capital to launch Sequoia Capital China Intelligent Healthcare Genomics Incubator for catalyzing start-up ecosystem in China.
Reasons to subscribe to China genotyping market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China genotyping market databook
-
Our clientele includes a mix of genotyping market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China genotyping market , including forecasts for subscribers. This country databook contains high-level insights into China genotyping market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China genotyping market size, by product, 2018-2030 (US$M)
China Genotyping Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
